NeOnc Technologies Holdings is set to present clinical data from its two brain cancer treatment programs, NEO100 (intranasal) and NEO212 (oral), at the Society for Neuro-Oncology meeting on November 13. These programs target aggressive brain cancers with innovative delivery methods to overcome the blood-brain barrier, aiming to improve patient outcomes. The company plans a pivotal trial involving 500 patients across 30 hospitals in three countries, highlighting its international ambitions. Investors may watch for clinical updates and potential market impact as NeOnc advances toward commercialization.
NeOnc Technologies Holdings is advancing two brain cancer treatment programs as of November 2, 2026, 23:14 WIB. For readers following health-sector stocks, here is Pluang's market snapshot: out of 150 priced US health stocks, 55 rose and 94 fell. Notable movers include IDXX at USD 644.74 (+16.97%), DNA at USD 9.69 (-13.71%), and TWST at USD 134.53 (-11.95%), with typical hold times ranging from 9 to 47 days.
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
The global wealth management software market, valued at $6.28 billion in 2025, is projected to reach $18.77 billion by 2033, growing at a 14.7% CAGR. Growth is fueled by rising adoption of AI, automation, and digital advisory tools that enhance workf...
Maurizio Mian, known as the pioneer of influencer culture, has launched a new micro-drama series called 'The Experiment.' The show features popular social media personalities living in luxury while exploring whether happiness can be measured and incr...
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
